Skip to content
    Inve.money
    Earnings calls

    Hester Bios concall ledger

    Every earnings call for HESTERBIO — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    HESTERBIO · 4 transcripts · Healthcare · latest Q3 FY26
    Q3 FY26Published 30 Jan 2026Call held 30 Jan 2026

    HESTERBIO Q3 FY26 Earnings Call Transcript & Analysis

    Stand-alone Revenue Growth0.12%+12% YoYStand-alone PAT Growth1.4%+140% YoY9M Stand-alone Revenue Growth-0.05%−5% YoY9M Stand-alone Profit Growth0.16%+16% YoYConsolidated Revenue Growth0.22%+22% YoY

    Stand-alone Revenue Growth 0.12% (+12% YoY); Stand-alone PAT Growth 1.4% (+140% YoY); 9M Stand-alone Revenue Growth -0.05% (−5% YoY). Stand-alone revenue grew 12% in Q3 FY26, with PAT up 140% YoY.

    Read full transcript & analysis